For example, MALAT1 regulated cisplatin resistance through the miR-101-3p/VEGF-C axis in bladder cancer (Liu et al. 2019a) and the hindering of MALAT1/miR-199a/ZHX1 axis suppressed the progression of glioblastoma (Liao et al. 2019). Here, VEGFC is linked to urinary bladder cancer.